Endra life sciences inc. (NDRA)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16
Cash Flows from Operating Activities
Net loss

-13,305

-9,796

-5,376

-2,775

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

80

68

61

64

Common stock, options and warrants issued for services

1,399

1,367

1,002

230

Additional warrants issued during exchange

-

-

-

-5

Amortization of debt discount

2,355

729

-

899

Impairment of other assets

249

0

-

-

Imputed interest on promissory notes

-

-

1

3

Amortization of debt discount

-

-

711

-

Impairment of inventory

0

287

0

-

Amortization of right of use assets

34

0

-

-

Changes in operating assets and liabilities:
Increase in accounts receivable

0

-6

6

0

Increase in prepaid expenses

-28

77

67

0

Decrease in lease liability

30

0

-

-

Increase in inventory

53

155

151

-58

Decrease in other asset

106

259

3

2

Increase in accounts payable and accrued liabilities

760

126

528

198

Net cash used in operating activities

-8,588

-7,702

-3,300

-1,315

Cash Flows from Investing Activities:
Purchases of fixed assets

43

100

7

-

Purchases of fixed assets

-

-

-

0

Net cash used in investing activities

-43

-100

-7

0

Cash Flows from Financing Activities
Proceeds from notes payable

-

-

-

50

Repayment of notes payable

-

-

50

-132

Proceeds from senior secured convertible promissory notes, net of fees

2,490

935

225

1,254

Proceeds from issuance of Series A Convertible Preferred Stock

5,344

0

-

-

Proceeds from issuance of Series B Convertible Preferred Stock

375

0

-

-

Proceeds from issuance of common stock

125

7,736

8,590

5

Net cash provided by financing activities

8,335

8,671

8,765

1,441

Net decrease (increase) in cash

-297

869

5,456

125

Supplemental disclosures:
Interest paid

0

40

0

-

Income tax paid

0

0

0

-

Interest Paid

-

-

-

0

Income tax paid

-

-

-

0

Supplemental disclosures of non-cash Items:
Discount on convertible notes

2,490

587

225

0

Common shares to be issued for accrued salaries - related parties

-

-

-

60

Conversion of convertible notes and accrued interest

140

1,077

1,726

0

Exchange of balance in convertible notes and accrued interest for Series A preferred stock

1,943

0

-

-

Deemed dividend

4,219

0

-

-

Right of use asset

404

0

-

-

Lease liability

409

0

-

-